Adaptive Bleeding Control Systems for Extreme Environments

Publication ID: 24-11857788_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Bleeding Control Systems for Extreme Environments,” Published Technical Disclosure No. 24-11857788_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857788_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,788.

Summary of the Inventive Concept

This inventive concept discloses specialized systems and methods for reducing bleeding in patients under unique operational environments, such as high-altitude medical emergencies, natural disasters, high-security situations, search and rescue operations, and medical evacuations.

Background and Problem Solved

The original patent, 'Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation', provides a general approach to preventing and/or treating bleeding in a subject. However, it does not address the specific challenges posed by extreme environments, where conventional bleeding control methods may be ineffective or impractical. This inventive concept adapts the original patent's principles to create specialized solutions for these niche situations.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of systems and methods tailored to specific extreme environments. For example, a portable, low-oxygen-operable apparatus can be used during high-altitude medical emergencies. A waterproof apparatus can be employed during natural disasters. An apparatus integrated with a surgical table can be used in high-security environments. A wearable, extreme-weather-resistant device can be used during search and rescue operations. A handheld, vital-sign-feedback-enabled device can be used during medical evacuations. Each of these variations incorporates the original patent's coordinated trigeminal and vagal nerve stimulation principles, adapted to the specific operational constraints and requirements of the target environment.

Novelty and Inventive Step

The new claims introduce novel, non-obvious adaptations of the original patent's principles to address the unique challenges of extreme environments. These adaptations include specialized apparatus designs, operating modes, and control systems that enable effective bleeding control in situations where conventional methods are inadequate.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include, but are not limited to, systems for use in extreme temperatures, high-radiation environments, or confined spaces. Variations could also include different stimulation protocols, electrode configurations, or power sources tailored to specific operational scenarios.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including emergency medical services, search and rescue, military operations, and disaster relief. The market for these specialized bleeding control systems is substantial, given the growing need for effective medical solutions in extreme environments.

Original Patent Information

Patent NumberUS 11,857,788
TitleMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Assignee(s)THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH